Does Prana Biotechnology stock pay a dividend?
Prana Biotechnology does not currently pay a dividend. Prana Biotechnology does not have a long track record of dividend growth. In the past three months, Prana Biotechnology insiders have not sold or bought any company stock. How were Prana Biotechnology's earnings last quarter?
What does Prana Biotechnology Limited (PBT) earn?
Prana Biotechnology Limited (ASX:PBT) issued its earnings results on Thursday, February, 28th. The biotechnology company reported ($0.01) earnings per share for the quarter. View Prana Biotechnology's earnings history. Who are Prana Biotechnology's key executives?
What is the market capitalization of Prana Biotechnology?
Prana Biotechnology has a market capitalization of $0.00. How many employees does Prana Biotechnology have? Prana Biotechnology employs 14 workers across the globe.
Where can I find Prana Biotechnology's mailing address?
Prana Biotechnology's mailing address is PO Box 655, MELBOURNE, VIC 3053, Australia. The biotechnology company can be reached via phone at +61-3-93494906. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
How were Prana Biotechnology's earnings last quarter?
Prana Biotechnology Limited (ASX:PBT) announced its earnings results on Thursday, February, 28th. The biotechnology company reported ($0.01) earnin...
Who are Prana Biotechnology's key executives?
Prana Biotechnology's management team includes the following people: Mr. Geoffrey Paul Kempler , Co-Founder, Exec. Chairman, CEO & MD (Age 64) M...
Who are some of Prana Biotechnology's key competitors?
Some companies that are related to Prana Biotechnology include 3SBio (TRSBF) , 45525 (CUR.TO) (CUR) , Abattis Bioceuticals (ATTBF) , Abcam (ABC...
What is Prana Biotechnology's stock symbol?
Prana Biotechnology trades on the ASX under the ticker symbol "PBT."
How much money does Prana Biotechnology make?
Prana Biotechnology (ASX:PBT) has a market capitalization of $0.00.
How many employees does Prana Biotechnology have?
Prana Biotechnology employs 14 workers across the globe.
What is Prana Biotechnology's official website?
The official website for Prana Biotechnology is pranabio.com .
How can I contact Prana Biotechnology?
Prana Biotechnology's mailing address is PO Box 655, MELBOURNE, VIC 3053, Australia . The biotechnology company can be reached via phone at +61-3...
56 Biggest Movers From Friday
33 Stocks Moving In Friday's Mid-Day Session
Gainers Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share.
How many X is Zacks?
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform.
What is style score?
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
What is ZER research?
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
How many sectors are there in Zacks?
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
What is Prana Biotechnology?
The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank.
What are the different grades for stocks?
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses.
Can you add videos to your watch history?
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
What is Prana Biotechnology?
Videos you watch may be added to the TV's watch history and influence TV recommendations. To avoid this, cancel and sign in to YouTube on your computer.
What is PBT2 used for?
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Can clinical trial data move stock price?
The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Contact Information.
What is Alterity Therapeutics' stock symbol?
Clinical trial data can move a stock price like virtually nothing else on Wall Street. Given the proclivity for volatility, investing in small- and mid-cap biotech is definitely not for the faint
Where are Alterity Therapeutics' headquarters?
Alterity Therapeutics trades on the NASDAQ under the ticker symbol "PRAN."
What is MarketBeat community ratings?
Alterity Therapeutics is headquartered at Level 3 460 Bourke Street, Melbourne C3, 3000.
How much of Alterity Therapeutics stock is owned by insiders?
MarketBeat's community ratings are surveys of what our community members think about Alterity Therapeutics and other stocks. Vote “Outperform” if you believe PRAN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PRAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
What is Alterity Therapeutics?
38.80% of the stock of Alterity Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.
Does Alterity Therapeutics pay dividends?
engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
